Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro

This publication has 25 references indexed in Scilit:

• Effect of sera from women with systemic lupus erythematosus or antiphospholipid syndrome and recurrent abortions on human placental explants in culture
  Teratology, 2002
• Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment
  Obstetrics & Gynecology, 2002
• Trophoblast turnover in health and disease
  Fetal and Maternal Medicine Review, 2002
• Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials
  Obstetrics & Gynecology, 2002
• Physiologic concentrations of magnesium and placental apoptosis: prevention by antioxidants
  Published by Wolters Kluwer Health ,2001
• Heparin Differentially Regulates the Interaction of Fibroblast Growth Factor-4 with FGF Receptors 1 and 2
  Biochemical and Biophysical Research Communications, 1999
• Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?
  Journal of Clinical Investigation, 1997
• Monoclonal Antibody against Phosphatidylserine Inhibits in Vitro Human Trophoblastic Hormone Production and Invasion1
  Biology of Reproduction, 1997
• Anti‐annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody
  American Journal of Hematology, 1994
• Lupus anticoagulant activity of some antiphospholipid antibodies against phospholipid bound beta 2 glycoprotein I.
  Journal of Clinical Pathology, 1993